Develop a method to extract and analyze metabolites and lipids from one small dried blood spot (DBS), expanding the molecular information obtainable from limited blood samples.
Approach:
Extraction: A biphasic extraction modeled on the Folch method separated lipids into an organic phase and metabolites into an aqueous phase. A reduced reconstitution volume concentrated analytes; glass labware was used to minimize polyethylene glycol contamination.
Analysis: Both extracts were analyzed by LC–HRMS/MS. Metabolites were processed in MZmine and identified using MS/MS spectral matching and an in-house library; lipids were annotated with LipidMatch.
Reproducibility: Repeated DBS extractions from the same donors on different days were analyzed using the same workflow and compared.
Key Findings:
The method enables metabolite and lipid analysis from a single 10 µL DBS sample.
The combined datasets are generated from the same specimen and can be integrated directly.
DBS results may not be directly comparable with plasma or serum reference values because concentrations can differ by specimen type.
Drying, storage, hematocrit, and spot volume can affect measured molecular profiles.
Interpretation:
The authors describe the method as a way to obtain a broader biochemical profile from a small DBS sample. They state that further method development and clinical validation with samples from affected patients are needed before diagnostic application.
Limitations:
The small sample volume can produce low analyte signals.
Pre-analytical factors, including drying, storage, hematocrit, and spot volume, may introduce variability.
The reported work has not yet been clinically validated for diagnostic use.
Proteomics and integration with other omics data have not yet been performed on these samples.
Conclusion:
Future work described by the authors includes evaluating alternative extraction procedures, adding proteomic analysis, improving sensitivity and throughput, and expanding spectral libraries.
UK pilot study finds that whole genome sequencing can uncover genetic conditions in children, leading to changes in clinical management and specialist care